Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The GUMMMy Bear Squad touting Gum Tech (NASDAQ: GUMM) -- Ignore unavailable to you. Want to Upgrade?

To: StockMiser who wrote (175)	3/31/2000 11:16:00 AM
From: Mad2	Read Replies (2) \| Respond to of 207

The entire substance of the PR release is; March 31 /PRNewswire/ -- Gum Tech International, Inc., (Nasdaq: GUMM - news) announced today that Gel Tech LLC, its joint venture with BioDelivery Technologies, Inc., has developed Zicam(TM) Allergy Relief, a homeopathic nasal gel designed to provide temporary relief of allergy symptoms due to allergic rhinitis (hay fever). The product is being introduced this week at an ECRM Cough/Cold and Analgesics Trade Conference in West Palm Beach, Florida. The claims are toned down from ZICAM for colds, to designed to provide temporary relief. Who knows whats in the stuff